AIM2's role in intestinal stem cell changes during gut inflammation
Impact of AIM2 on Intestinal Stem Cell Differentiation During Inflammation
Researchers are looking at how a protein called AIM2 changes intestinal stem cells during gut inflammation, which could help people with inflammatory bowel disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Arizona NIH-funded |
| Lab location | 1 site (Tucson, United States) |
| Project ID | NIH-11251279 on NIH RePORTER |
What this research studies
This project looks at how the protein AIM2 affects the way intestinal stem cells grow and become different types of cells that line the gut during inflammation. Scientists will use mouse models and laboratory-grown intestinal cells to study how AIM2 and related immune sensors interact with gut microbes and immune signals. The work focuses on molecular mechanisms, including inflammasome and non-inflammasome functions, to understand how disruptions can lead to chronic conditions such as IBD. Although it is mainly laboratory and animal research, the findings could point to new targets for treatments or future patient-focused studies.
Who could benefit from this research
Good fit: People with inflammatory bowel disease (Crohn's disease or ulcerative colitis) who are interested in new research directions would be most relevant to follow or participate in related future studies.
Not a fit: Those with non-inflammatory digestive conditions or people expecting immediate clinical treatment changes are unlikely to receive direct benefit from this basic science project.
Why it matters
Potential benefit: If successful, this could point to new ways to protect or repair the gut lining and lead to therapies for inflammatory bowel disease.
How similar studies have performed: Previous animal and laboratory studies have suggested AIM2 and related immune sensors influence gut inflammation, but targeting stem cell differentiation is a newer and less-tested approach.
Where this research is happening
Tucson, United States
- University of Arizona — Tucson, United States (Active)
Researchers
- Principal investigator: Wilson, Justin Ethan — University of Arizona
- Study coordinator: Wilson, Justin Ethan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.